BioSpace News Archive

BioForest

Impel Pharmaceuticals to Present New Real-World Data for Trudhesa® at the 65th Annual Scientific Meeting of the American Headache Society

Impel Pharmaceuticals announced it will present new real-world data adding to the growing body of evidence supporting Trudhesa® nasal spray as an effective acute therapy for migraine management.

June 15, 2023
·
14 min read
BioForest

Avalyn Pharma Highlighting Inhalation Platform at Upcoming H.C. Wainwright and Hanson Wade Conferences in June 2023

Avalyn Pharma Inc. announced that CFO Marc Schneebaum will present at the H.C. Wainwright 2nd Annual Private Company Showcase, which is taking place June 20-22, 2023 on Kiawah Island, SC.

June 15, 2023
·
2 min read
Biotech Beach

TRACON Pharmaceuticals Announces Enforcement Action to Collect Binding Arbitration Award from I-Mab Biopharma

TRACON Pharmaceuticals, Inc. announced that it has commenced court proceedings in Hong Kong and the Cayman Islands to enforce an April 2023 arbitration award against I-Mab for approximately $23.0 million, plus interest.

June 15, 2023
·
3 min read
Business

Femasys Inc. Replaces Two Board Members with Seasoned Industry Leaders in the Life Sciences

Femasys Inc. announced that it has appointed Mr. Keith J. Kendall and Mr. Alistair Milnes to its board of directors.

June 15, 2023
·
5 min read
Bio NC

Satsuma Pharmaceuticals and SNBL Announce Three Abstracts on STS101 for the Acute Treatment of Migraine to be Presented at the American Headache Society’s 65th Annual Scientific Meeting

Satsuma Pharmaceuticals, Inc., and its corporate parent, Shin Nippon Biomedical Laboratories, Ltd., announced that three abstracts describing efficacy and safety results from the STS101 Phase 3 efficacy trial were selected for presentation at the American Headache Society’s 65th Annual Scientific Meeting.

June 15, 2023
·
7 min read
Drug Development

Helocyte Announces $3.22 Million Grant from the National Cancer Institute for Triplex Phase 2 Clinical Trial Program

Helocyte, Inc., a subsidiary company of Fortress Biotech, Inc., announced that the National Cancer Institute has awarded a $3.22 million grant to City of Hope for clinical studies of Triplex, a cytomegalovirus vaccine being developed by Helocyte and City of Hope.

June 15, 2023
·
9 min read
BioMidwest

Sensus Healthcare to Participate in the Maxim Group Virtual Healthcare Conference Hosted by M-Vest

Sensus Healthcare, Inc. announces its participation in the Maxim Group Virtual Healthcare Conference hosted by M-Vest.

June 15, 2023
·
1 min read
Pharm Country

Indaptus Therapeutics to Participate in the Maxim Group Virtual Healthcare Conference

Indaptus Therapeutics, Inc., a biotechnology company focused on discovering and developing transformative therapeutics for patients, announced that CEO Jeffrey A. Meckler will participate in the Maxim Group Virtual Healthcare Conference presented by Maxim Group and hosted by M-Vest.

June 15, 2023
·
6 min read
Nemaura Medical to Exhibit and Provide Live Product Demonstrations of Its Non-invasive Glucose Sensor at the 83rd Scientific Sessions of the American Diabetes Association June 23-26, 2023

Nemaura Medical, Inc. announces it will exhibit and provide product demonstrations of its non-invasive daily-wear glucose sensor platform at the 83rd Scientific Sessions of the American Diabetes Association.

June 15, 2023
·
3 min read
BioMidwest

Daxor Accelerates Blood Volume Analysis Adoption with the Launch of ezBVA Lab Services

Daxor Corporation announces the launch of a new service designed to drive faster adoption and provide greater prescriber access to Daxor’s innovative blood volume analysis technology.

June 15, 2023
·
3 min read